# Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

> **NCT01040026** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Treatment with in vitro expanded haploidentical NK cells

## Key facts

- **NCT ID:** NCT01040026
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2016-09
- **Final completion:** 2020-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040026, "Expanded Natural Killer (NK) Cells for Multiple Myeloma Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01040026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*